login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock News
USA
-
Nasdaq
- NASDAQ:IOVA -
US4622601007
-
Common Stock
2.24
USD
+0.06 (+2.75%)
Last: 11/21/2025, 8:00:02 PM
2.25
USD
+0.01 (+0.45%)
After Hours:
11/21/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IOVA Latest News, Press Relases and Analysis
All
Press Releases
17 days ago - By: Chartmill
- Mentions:
CCOI
AMSC
ASPN
GDEN
...
Top movers in Thursday's session
17 days ago - By: Chartmill
- Mentions:
CCOI
AMSC
ASPN
GDEN
...
Top stock movements in today's session.
2 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12 days ago - By: The Motley Fool
Down 75% in 12 Months, Can Iovance Biotherapeutics Stock Turn Things Around?
16 days ago - By: Zacks Investment Research
- Mentions:
ALKS
ANIP
CRMD
IOVA Soars 28% on Narrower-Than-Expected Loss in Q3, Revenues Up Y/Y
16 days ago - By: The Motley Fool
- Mentions:
NTLA
2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street
17 days ago - By: Chartmill
- Mentions:
AMSC
ASPN
GDEN
ELF
...
Gapping stocks in Thursday's session
17 days ago - By: Stocktwits
Why Are IOVA Shares Rising Today?
17 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
17 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
17 days ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
18 days ago - By: Zacks Investment Research
- Mentions:
DVAX
Dynavax Technologies (DVAX) Surpasses Q3 Earnings Estimates
18 days ago - By: Benzinga
Examining the Future: Iovance Biotherapeutics's Earnings Outlook
19 days ago - By: Zacks Investment Research
- Mentions:
STOK
Stoke Therapeutics, Inc. (STOK) Reports Q3 Loss, Beats Revenue Estimates
20 days ago - By: Zacks Investment Research
- Mentions:
ARCT
Earnings Preview: Arcturus Therapeutics (ARCT) Q3 Earnings Expected to Decline
20 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
20 days ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
25 days ago - By: Bragar Eagel & Squire
IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders
a month ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
a month ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
a month ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: Bragar Eagel & Squire
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
2 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3 months ago - By: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics to Present at Upcoming Conferences
Please enable JavaScript to continue using this application.